N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile

C153H177F5N36O — CID 157360337

IUPACN-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile
SMILESCN(Cc1cccc(C#N)c1)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CCCC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)C1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3cccnc23)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(N3CCOCC3)c3ccccc23)CC1.Cc1cc(F)ccc1CN(C)CC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)C1
InChIInChI=1S/C26H29FN6.C26H32FN5O.C26H28FN5.C25H28FN7.C25H31FN6.C25H29N7/c1-18-14-21(27)9-8-20(18)17-31(2)15-19-11-13-33(16-19)26-23-7-5-4-6-22(23)25(29-30-26)24-10-12-28-32(24)3;1-19-17-21(27)8-7-20(19)18-30(2)22-9-11-31(12-10-22)25-23-5-3-4-6-24(23)26(29-28-25)32-13-15-33-16-14-32;1-18-16-21(27)11-10-20(18)7-5-6-19-13-15-32(17-19)26-23-9-4-3-8-22(23)25(29-30-26)24-12-14-28-31(24)2;1-17-15-19(26)7-6-18(17)16-31(2)20-9-13-33(14-10-20)25-24-21(5-4-11-27-24)23(29-30-25)22-8-12-28-32(22)3;1-17-15-19(26)8-7-18(17)16-30(2)20-10-13-32(14-11-20)25-22-6-4-5-21(22)24(28-29-25)23-9-12-27-31(23)3;1-30(17-19-6-3-5-18(15-19)16-26)20-10-13-32(14-11-20)25-22-8-4-7-21(22)24(28-29-25)23-9-12-27-31(23)2/h4-10,12,14,19H,11,13,15-17H2,1-3H3;3-8,17,22H,9-16,18H2,1-2H3;3-4,8-12,14,16,19H,5-7,13,15,17H2,1-2H3;4-8,11-12,15,20H,9-10,13-14,16H2,1-3H3;7-9,12,15,20H,4-6,10-11,13-14,16H2,1-3H3;3,5-6,9,12,15,20H,4,7-8,10-11,13-14,17H2,1-2H3
InChIKeyBIOJNSRDVMYNQZ-UHFFFAOYSA-N
MW2631.34 g/mol
LogP25.00
Rot. Bonds32

About N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile

N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile (PubChem CID 157360337) has the molecular formula C153H177F5N36O and a molecular weight of 2631.34 g/mol. Its IUPAC name is N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile.

Molecular Properties

Compound NameN-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile
PubChem CID157360337
Molecular FormulaC153H177F5N36O
Molecular Weight2631.34 g/mol
Exact Mass2629.48
IUPAC NameN-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile
SMILESCN(Cc1cccc(C#N)c1)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CCCC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)C1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3cccnc23)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(N3CCOCC3)c3ccccc23)CC1.Cc1cc(F)ccc1CN(C)CC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)C1
InChIInChI=1S/C26H29FN6.C26H32FN5O.C26H28FN5.C25H28FN7.C25H31FN6.C25H29N7/c1-18-14-21(27)9-8-20(18)17-31(2)15-19-11-13-33(16-19)26-23-7-5-4-6-22(23)25(29-30-26)24-10-12-28-32(24)3;1-19-17-21(27)8-7-20(19)18-30(2)22-9-11-31(12-10-22)25-23-5-3-4-6-24(23)26(29-28-25)32-13-15-33-16-14-32;1-18-16-21(27)11-10-20(18)7-5-6-19-13-15-32(17-19)26-23-9-4-3-8-22(23)25(29-30-26)24-12-14-28-31(24)2;1-17-15-19(26)7-6-18(17)16-31(2)20-9-13-33(14-10-20)25-24-21(5-4-11-27-24)23(29-30-25)22-8-12-28-32(22)3;1-17-15-19(26)8-7-18(17)16-30(2)20-10-13-32(14-11-20)25-22-6-4-5-21(22)24(28-29-25)23-9-12-27-31(23)3;1-30(17-19-6-3-5-18(15-19)16-26)20-10-13-32(14-11-20)25-22-8-4-7-21(22)24(28-29-25)23-9-12-27-31(23)2/h4-10,12,14,19H,11,13,15-17H2,1-3H3;3-8,17,22H,9-16,18H2,1-2H3;3-4,8-12,14,16,19H,5-7,13,15,17H2,1-2H3;4-8,11-12,15,20H,9-10,13-14,16H2,1-3H3;7-9,12,15,20H,4-6,10-11,13-14,16H2,1-3H3;3,5-6,9,12,15,20H,4,7-8,10-11,13-14,17H2,1-2H3
InChIKeyBIOJNSRDVMYNQZ-UHFFFAOYSA-N
XLogP25.00
TPSA328.57 Ų
H-Bond Donors
H-Bond Acceptors37
Rotatable Bonds32
Heavy Atoms195
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002631.34
LogP ≤ 525.00
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1037

Analyze N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile?
The IUPAC name of N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile (CID 157360337) is N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile.
What is the SMILES notation for N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile?
The canonical SMILES for N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile is CN(Cc1cccc(C#N)c1)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CCCC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)C1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3c2CCC3)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(-c3ccnn3C)c3cccnc23)CC1.Cc1cc(F)ccc1CN(C)C1CCN(c2nnc(N3CCOCC3)c3ccccc23)CC1.Cc1cc(F)ccc1CN(C)CC1CCN(c2nnc(-c3ccnn3C)c3ccccc23)C1.
What is the InChIKey of N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile?
The InChIKey is BIOJNSRDVMYNQZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C26H29FN6.C26H32FN5O.C26H28FN5.C25H28FN7.C25H31FN6.C25H29N7/c1-18-14-21(27)9-8-20(18)17-31(2)15-19-11-13-33(16-19)26-23-7-5-4-6-22(23)25(29-30-26)24-10-12-28-32(24)3;1-19-17-21(27)8-7-20(19)18-30(2)22-9-11-31(12-10-22)25-23-5-3-4-6-24(23)26(29-28-25)32-13-15-33-16-14-32;1-18-16-21(27)11-10-20(18)7-5-6-19-13-15-32(17-19)26-23-9-4-3-8-22(23)25(29-30-26)24-12-14-28-31(24)2;1-17-15-19(26)7-6-18(17)16-31(2)20-9-13-33(14-10-20)25-24-21(5-4-11-27-24)23(29-30-25)22-8-12-28-32(22)3;1-17-15-19(26)8-7-18(17)16-30(2)20-10-13-32(14-11-20)25-22-6-4-5-21(22)24(28-29-25)23-9-12-27-31(23)3;1-30(17-19-6-3-5-18(15-19)16-26)20-10-13-32(14-11-20)25-22-8-4-7-21(22)24(28-29-25)23-9-12-27-31(23)2/h4-10,12,14,19H,11,13,15-17H2,1-3H3;3-8,17,22H,9-16,18H2,1-2H3;3-4,8-12,14,16,19H,5-7,13,15,17H2,1-2H3;4-8,11-12,15,20H,9-10,13-14,16H2,1-3H3;7-9,12,15,20H,4-6,10-11,13-14,16H2,1-3H3;3,5-6,9,12,15,20H,4,7-8,10-11,13-14,17H2,1-2H3.
What are the key properties of N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile?
N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile has a molecular weight of 2631.34 g/mol, XLogP of 25.00, 32 rotatable bonds, 0 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[1-[4-(2-methylpyrazol-3-yl)phthalazin-1-yl]pyrrolidin-3-yl]methanamine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-[5-(2-methylpyrazol-3-yl)pyrido[2,3-d]pyridazin-8-yl]piperidin-4-amine;N-[(4-fluoro-2-methylphenyl)methyl]-N-methyl-1-(4-morpholin-4-ylphthalazin-1-yl)piperidin-4-amine;1-[3-[3-(4-fluoro-2-methylphenyl)propyl]pyrrolidin-1-yl]-4-(2-methylpyrazol-3-yl)phthalazine;3-[[methyl-[1-[1-(2-methylpyrazol-3-yl)-6,7-dihydro-5H-cyclopenta[d]pyridazin-4-yl]piperidin-4-yl]amino]methyl]benzonitrile is sourced from PubChem (CID 157360337), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).